| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/03/2006 | DE60115402T2 Neues selbstemulgierendes arzneistoffverabreichungssystem New self-emulsifying drug delivery system |
| 08/03/2006 | DE4427056B4 Neue Carboxymethylidencycloheptimidazol-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als antihypertensive und anticongestive Mittel New Carboxymethylidencycloheptimidazol derivatives, processes for their preparation and their use as antihypertensive agents and anticongestive |
| 08/03/2006 | DE3942642B4 Abgepackte Mundpflegemittel mit Zahnbelag verhindernden Eigenschaften Packaged oral care products with plaque-preventing properties |
| 08/03/2006 | DE10394175T5 Zusammensetzung mit einem botanischen Extrakt mit Anti-Krebs- oder phytoöstrogener Aktivität, enthaltend Prenyflavonoide Composition with a botanical extract with anti-cancer activity or phytoöstrogener containing Prenyflavonoide |
| 08/03/2006 | DE10132725A1 Substituierte γ-Lactonverbindungen Substituted γ-lactone |
| 08/03/2006 | CA2599228A1 Hiv inhibiting 2-( 4-cyanophenylamino) pyrimidine derivatives |
| 08/03/2006 | CA2596619A1 The use of flupirtine for the treatment of overactive bladder and associated diseases, and for the treatment of irritable bowel syndrome |
| 08/03/2006 | CA2596548A1 Multiple unit oral sustained release preparation and process for production of the same |
| 08/03/2006 | CA2596527A1 Igf-1r inhibitors |
| 08/03/2006 | CA2596371A1 Agent for control degranulation reaction and cytokine production |
| 08/03/2006 | CA2596237A1 Diamine derivative |
| 08/03/2006 | CA2596235A1 Spiroketal derivatives and use thereof as diabetic medicine |
| 08/03/2006 | CA2596230A1 Composition for inhibiting expression of target gene |
| 08/03/2006 | CA2596215A1 Nebulizer formulation of levalbuterol and ipratropium |
| 08/03/2006 | CA2596156A1 New derivatives of heterocyclic oximes, their preparation process and the pharmaceutical compositions that they contain |
| 08/03/2006 | CA2596144A1 Compounds for treating inflammatory and demyelinating diseases |
| 08/03/2006 | CA2596131A1 Liposomal compositions for parenteral delivery of agents |
| 08/03/2006 | CA2596060A1 Novel pyrimidine nucleoside compound or salt thereof |
| 08/03/2006 | CA2596058A1 Method of producing coated fine particles |
| 08/03/2006 | CA2596053A1 Esterified catechins, processes for producing the same, and foods and beverages as well as cosmetics containing such esterified catechins |
| 08/03/2006 | CA2595994A1 Organic compounds useful for the treatment of alzheimer's disease, their use and method of preparation |
| 08/03/2006 | CA2595988A1 Extended release formulation of levetiracetam |
| 08/03/2006 | CA2595986A1 7-{4-[2-(2,6-dichlor0-4-methylphenoxy)-ethoxy]phenyl}-3,9-diazabicyclo[3.3.1]non-6-ene-6-carboxylic acid cyclopropyl-(2,3-dimethylbenzyl)amides as inhibitors of renin for the treatment of hypertension |
| 08/03/2006 | CA2595975A1 Novel heterocyclic oxime derivatives, method for preparing same and use thereof as hypoglycaemic or hypolipidemic agents |
| 08/03/2006 | CA2595958A1 Substituted 5-phenyl pyrimidines i in therapy |
| 08/03/2006 | CA2595942A1 Treatment of degenerative diseases with the x-linked inhibitor of apoptosis |
| 08/03/2006 | CA2595898A1 Method and composition for treating central nervous system disorders |
| 08/03/2006 | CA2595896A1 Inhibitor nucleic acids |
| 08/03/2006 | CA2595889A1 N-halogenated amino acids and n,n-dihalogenated amino acids in combination with hypohalous acids |
| 08/03/2006 | CA2595882A1 Thieno [2,3-d] pyrimidine compounds as inhibitors of adp-mediated platelets aggregation |
| 08/03/2006 | CA2595879A1 Analgesic compositions |
| 08/03/2006 | CA2595875A1 Methods of diagnosis and treatment for asthma, allergic rhinitis and other respiratory diseases based on haplotype association |
| 08/03/2006 | CA2595855A1 Pyrazine compounds for inflammation and immune-related uses |
| 08/03/2006 | CA2595848A1 Erastin and erastin binding proteins, and uses thereof |
| 08/03/2006 | CA2595749A1 Combination therapy with triterpenoid compounds and proteasome inhibitors |
| 08/03/2006 | CA2595728A1 2-phenyl-indoles as prostaglandin d2 receptor antagonists |
| 08/03/2006 | CA2595726A1 Anti-cancer dna vaccine employing plasmids encoding mutant oncoprotein antigen and calreticulin |
| 08/03/2006 | CA2595711A1 Methods and compositions using 4-amino-2-(3-methyl-2,6-dioxopiperidin-3-yl)-isoindole-1-3-dione |
| 08/03/2006 | CA2595675A1 Form iv crystalline celecoxib |
| 08/03/2006 | CA2595651A1 Methods of treating various conditions by administration of sustained release l-arginine |
| 08/03/2006 | CA2595607A1 Substituted arylamine compounds and their use as 5-ht6 modulators |
| 08/03/2006 | CA2595605A1 Phenyl methanone derivatives and their use as glycine transporter 1 inhibitors |
| 08/03/2006 | CA2595542A1 3-heteroaryl-3-hydroxy-2-amino-propyl amines and related compounds having analgesic and/or immuno stimulant activity |
| 08/03/2006 | CA2595522A1 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immuno stimulant activity |
| 08/03/2006 | CA2595519A1 Methods of using as analgesics 1-benzyl-1-hydroxy-2,3-diamino-propyl amines, 3-benzyl-3-hydroxy-2-amino-propionic acid amides and related compounds |
| 08/03/2006 | CA2595376A1 Processes and compounds for the preparation of substituted naphthylindole derivatives |
| 08/03/2006 | CA2595348A1 Stabilised plant extract and its therapeutic use |
| 08/03/2006 | CA2595334A1 Polymorphic forms of aripiprazole and processes for making |
| 08/03/2006 | CA2595330A1 Spm 927 for add-on therapy of schizophrenia |
| 08/03/2006 | CA2595247A1 Indolopyridines, benzofuranopyridines and benzothienopyridines |
| 08/03/2006 | CA2595218A1 Indole derivatives having inhibitory activity against sodium-dependent glucose transporter |
| 08/03/2006 | CA2595170A1 Heterocyclic tetracyclic tetrahydrofuran derivatives as 5ht2 inhibitors in the treatment of cns disorders |
| 08/03/2006 | CA2594998A1 Substituted pyridazinyl-and pyrimidinyl-quinolin-4-ylamine analogues |
| 08/03/2006 | CA2594915A1 Phenyl-substituted pyrrolidones |
| 08/03/2006 | CA2594837A1 Novel indolopyridines, benzofuranopyridines and benzothienopyridines |
| 08/03/2006 | CA2594758A1 Delivery of bio-available compounds with anhydrous topical preparations |
| 08/03/2006 | CA2594721A1 Process for producing (z)-1-phenyl-1-(n,n-diethylaminocarbonyl)-2-phthalimidomethylcyclopropane |
| 08/03/2006 | CA2594713A1 Anticancer drug containing .alpha.,.alpha.,.alpha.-trifluorothymidine and thymidine phosphorylase inhibitor |
| 08/03/2006 | CA2594708A1 Chemical compounds |
| 08/03/2006 | CA2594698A1 Variable tint cosmetics |
| 08/03/2006 | CA2594693A1 Medicaments for the prevention or treatment of heart failure comprising administration of an anticholinergic |
| 08/03/2006 | CA2594692A1 Crystalline forms of rosuvastatin calcium salt |
| 08/03/2006 | CA2594690A1 Salts of aripiprazole |
| 08/03/2006 | CA2594687A1 Use of pyrimidylaminobenzamides for the treatment of diseases that respond to modulation of tie-2 kinase activity |
| 08/03/2006 | CA2594667A1 Compositions and therapeutic methods utilizing a combination of a 5-ht1f inhibitor and an nsaid |
| 08/03/2006 | CA2594582A1 Valnemulin salts with organic acids |
| 08/03/2006 | CA2593816A1 Synthesis of aryl pyrrolidones |
| 08/03/2006 | CA2593803A1 Thiazole-amide compounds and compsitions as protein kinase inhibitors |
| 08/03/2006 | CA2592608A1 Metabolites of 2-arylpropionic acid derivatives and pharmaceutical compositions containing them |
| 08/03/2006 | CA2592154A1 N-hydroxyamide derivatives and use thereof |
| 08/03/2006 | CA2592116A1 Anti-inflammatory medicaments |
| 08/03/2006 | CA2591537A1 Compounds for treating urinary incontinence |
| 08/03/2006 | CA2591062A1 Adapalene for the long-term treatment of acne vulgaris |
| 08/03/2006 | CA2589221A1 Anthelmintic imidazol-thiazole derivates |
| 08/03/2006 | CA2567789A1 Abasic oligonucleotide as carrier platform for antigen and immunostimulatory agonist and antagonist |
| 08/03/2006 | CA2534945A1 Pressure-sensitive adhesive composition applicable to nail and adhesive agent for nail |
| 08/02/2006 | EP1686181A2 Methods for enhanced virus-mediated DNA transfer using molecules with virus-and cell-binding domains |
| 08/02/2006 | EP1686162A2 Tape Preparation |
| 08/02/2006 | EP1686130A1 Pyrrolo[2,3-d]pyrimidine compounds as immunosuppressive agents |
| 08/02/2006 | EP1686127A1 New heterocyclylmethyl-substituted pyrazole derivatives and their use for treating cardiovascular diseases |
| 08/02/2006 | EP1686126A1 Salts of aripiprazole |
| 08/02/2006 | EP1686124A1 Wortmannin analogs and methods of using same |
| 08/02/2006 | EP1686122A1 Antitumor agent |
| 08/02/2006 | EP1686120A2 Methods and compositions utilizing quinazolinones |
| 08/02/2006 | EP1686119A1 Pyrimidine-4-one derivatives as ldl-pla2 inhibitors |
| 08/02/2006 | EP1686117A1 Polymorph and solvates of aripiprazole |
| 08/02/2006 | EP1686115A1 Valnemulin salts with organic acids |
| 08/02/2006 | EP1686113A1 Inhibitors of aspartyl protease |
| 08/02/2006 | EP1685876A1 Solid cosmetic cleansing composition |
| 08/02/2006 | EP1685849A1 Remedy for chronic pelvic pain syndrome |
| 08/02/2006 | EP1685845A1 Sialogogue and, containing the same, oral composition and food composition |
| 08/02/2006 | EP1685844A2 Immunostimulation by chemically modified RNA |
| 08/02/2006 | EP1685843A1 Oligosaccharide aldonic acids and their topical use |
| 08/02/2006 | EP1685842A2 Vascular endothelial growth factor (VEGF) nucleic acid ligand complexes |
| 08/02/2006 | EP1685841A1 Prevention and treatment of thromboembolic disorders |
| 08/02/2006 | EP1685840A2 Use of tetrahydrofolates for modulating the homocysteine level |
| 08/02/2006 | EP1685839A1 Pharmaceutical oral dosage form comprising a combination of an opioid agonist and opioid antagonist |
| 08/02/2006 | EP1685838A1 Compounds for the treatment of addictive disorders |
| 08/02/2006 | EP1685837A1 Percutaneous absorption type cerebral protective agent |
| 08/02/2006 | EP1685836A2 Antifungal activity of dicationic molecules |